Skip to main content
. 2016 Sep 1;18(9):532–538. doi: 10.1089/dia.2016.0171

FIG. 1.

FIG. 1.

Comparison of different treatment strategies for patient with type 1 diabetes during 1 year of follow-up: effect on HbA1c. Mean glycated hemoglobin levels (%) at baseline and 3, 6, 9, and 12 months in all groups. Asterisks denote P < 0.05 for comparison between the sensor-augmented regimens group and the two SMBG groups (insulin pump and MDI therapy) at each time point. MDIs, multiple daily injections; SMBG, self-monitoring of blood glucose.